Strax (1973) found that in patients over 50 mammography and clinical examination made a similar contribution to the detection of breast cancer, whilst under the age of 50 19% of the cancers were detected by mammography alone. In the present study 10 of the 20 cancers were found in the 40-49 age group and mammography and clinical examination contributed equally to this yield (Table 2) . Axillary node involvement was found in 5 patients. Thirteen patients were classified as TINO and the 8 cancers found by mammography only were in this group.
Microcalcification proved to be an important diagnostic feature and was the predominant abnormality in 7 of the cancers found by mammography alone, only one cancer being revealed as a mass. Diagnostic problems arose in 11 patients of the main study who were referred for biopsy because of the presence of fine calcification on the mammogram. Three of these patients were found to have 'intense' or 'extreme' intracystic papillomatosis and the remainder fibro-epithelial hyperplasia and some of these were regarded as aggressive hyperplasias on histological examination. This interesting group is to be the subject of careful follow up and further radiological pathological correlation will be needed.
Although the numbers are small and it is too early in the screening programme for definite conclusions to be made, the figures thus far do seem to indicate that mammography will be an important procedure in the early detection of breast cancer. Drug-induced lung disease has aroused great interest in recent years. The safety of any sedative in respiratory failure, the relationship of oral contraceptives to pulmonary embolism, the production of opportunistic and other infection after the exhibition of steroids and immunosuppressives, and the damage that high tension oxygen can produce have aroused particular comment (Feinmann 1974). Although attempts have been made to classify ill effects into toxic and allergic, the distinction is by no means clear cut and in many, e.g. aspirin and iodides, the mechanisms are not understood.
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Asthma, polyarteritis nodosa and systemic lupus erythematosus and some rarer conditions have been reviewed by Davies (1969) . Propranolol-induced asthma is now well recognized and understood, as are the type I and type Ill allergies produced by pituitary snuff. Polyarteritis nodosa in classical form was probably more common in the sulphonamide era and Wegener's granuloma may have an association with antibiotics. Systemic lupus is undoubtedly associated with the exhibition of a variety of drugs, and its manifestations are then usually mild and withdrawal effects a cure. This certainly seems particularly true of hydrallazine.
Of all the diffuse lung diseases produced by drugs, pulmonary eosinophilia is probably the most common in its trivial form, though the more serious chronic and life-threatening, disease is rare. The literature associates pulmonary eosinophilia particularly with nitrofurantoin and paraaminosalicylic acid (PAS), but in the 1940s it was commonly associated with sulphonamides. Ten to fourteen days after the exhibition of these drugs there was an exacerbation of fever, with blood eosinophilia and new pulmonary opacities. These cleared rapidly when the offending drug was withdrawn. Fiegenberg et al. (1967) have given a good account of this kind of illness associated with sulphonamides.
A much more serious, prolonged and ultimately life-threatening illness was described by Carrington et al. (1969) and discussed in detail by Liebow & Carrington (1969) . This illness, characterized by fever, loss of weight, sweats, cough and pulmonary consolidation, may be induced by the exhibition of drugs. A recent account in The Lancet (1974) describes several cases following prolonged uses of suiphasalazine. Carrington et al. (1969) have described a characteristic X-ray picture, with dense peripheral opacities, the hilar region remaining clear. The histological picture is that of pneumonic consolidation, with the eosinophil as the leukocyte filling alveoli and interstitial tissues and without arterial disease. However, biopsy should rarely be needed because the illness is always accompanied by a blood eosinophilia.
Of two patients with eosinophilic pneumonia of the chronic severe type, which may have been caused by the exhibition of sulphonamides, one was cured by the exhibition of high dosage steroids for a relatively short time; the other improved but showed evidence of permanent lung damage. Each year at least 10 % of the world's foodproducing capacity is lost because of weeds. Paraquat has become a herbicide of global importance. Its ability rapidly to destroy plants on coming into contact with the green parts, and to be rendered harmless by adsorption on to clay minerals in the soil permits the practice of nontillage agriculture. For this reason, following its introduction ten years ago, it is now used in over 130 countries and is of major significance in sustaining the so-called green revolution in food production.
Paraquat is a bipyridyl compound. In this country it is available in its concentrated form (known as Gramoxone and Dextrone) only to bona fide agricultural and horticultural workers.
It is sold to the general public as Weedol in 2 oz sachets each containing about 1 g paraquat.
The circumstances under which paraquat poisoning occurs are rarely, if ever, associated with its intended use. Most (but not all) poisoning is produced by the concentrated forms; many have resulted from the reprehensible practice of decanting the paraquat concentrate into unlabelled lemonade-type bottles. This brownish liquid is then mistaken, often by children, for some palatable beverage, and the realization that it was not comes too late to prevent tragic loss of life. It cannot be emphasized too strongly that putting a scheduled poison into an unlabelled bottle is not only foolhardy, it is against the law. Accident and the occasional homicidal attempt aside, paraquat has been extensively used as a means of committing suicide.
Our clinical experience comprises 18 patients of whom all but 2 were attempted suicides. Eight of these have survived. It is difficult to establish the lethal dose of paraquat. Patients rarely know how much they took, and there is often an unmeasurable loss of paraquat through vomiting and gastric lavage. The data available suggest that absorption of 20-40 mg/kg (between 1 and 2 g for a 70 kg man) can be fatal. Death has followed the ingestion of as little as one sachet of Weedol. Survival after higher doses may only reflect a failure to absorb the extra amount. Once absorbed, paraquat is widely distributed throughout the body tissues. The clinical picture after significant poisoning is one of progressive toxicity. Early symptoms relate to the irritant effect of paraquat on the mucosa of the gastrointestinal tract. The concentrate often causes burning of the mouth and pharynx and extensive ulceration may appear a day or two after ingestion. Gastric irritation may cause nausea and vomiting, and diarrhoea, sometimes bloody, may follow.
Patients who take massive doses die within a few hours, apparently because of the effect of paraquat on organs other than the lung. They become comatose and may have convulsions, and respiratory or cardiac arrest may rapidly ensue. If they survive long enough they show derangement of liver function because of centrilobular necrosis. Renal failure may result from acute tubular necrosis. Radiological changes in the lung begin to appear 2-3 days after poisoning. These are matched by the development of restrictive and sometimes obstructive ventilatory patterns, accompanied by progressive impairment of gaseous exchange. In the early stages the predominant lesion is pulmonary cedema. If the patient survives long enough, destruction of lung architecture, and a fibroblastic reaction leading to diffuse fibrosis ensue. Death results from respiratory failure.
